$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders
听
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Category:
Published on: 23 Oct 2024
Thomas Durcan鈥檚 project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
Category:
Published on: 16 Oct 2024
MRI data from large sample shows increased whole-brain connectivity in people with a second language
Neuroplasticity is the brain鈥檚 ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.
Category:
Published on: 11 Oct 2024
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Category:
Published on: 8 Oct 2024
RNA Nanotechnology - Gordon Research Conference (GRC)
Controlling RNA Sequence for Diagnostics and Therapeutic DeliveryJanuary 5 - 10, 2025
Ventura, California, United States
Category:
Published on: 8 Oct 2024
Scientists use stem cells to follow development of protein bodies characteristic of neurological disease
Category:
Published on: 8 Oct 2024
Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.
As an Assistant Professor of Human Genetics at 不良研究所, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.
Category:
Published on: 3 Oct 2024
G茅nome Qu茅bec invests up to $500,000 to boost RNA therapeutics innovation in Quebec
G茅nome Qu茅bec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in 不良研究所鈥檚 D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R鈥檚 Commercialization Priming funding program.
Category:
Published on: 2 Oct 2024
Join 不良研究所 Health Centre's next 鈥淢edical Genetics Grand Rounds鈥�
The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.
Category:
Published on: 26 Sep 2024
D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics
Montreal 鈥� September 17, 2024听 不良研究所鈥檚 D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.
Category:
Published on: 17 Sep 2024
A recent article in La Presse, , highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an RNA hub.
Here is a exerpt from the article (translated to english):听
Category:
Published on: 13 Sep 2024
The 不良研究所 community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University鈥檚 most rapidly growing disciplines and celebrate the generosity that is making it possible.听
The occasion was the official unveiling of signage for the Victor Phillip Dahdaleh Institute of Genomic Medicine, and on hand were the Institute鈥檚 UK-based benefactors, Victor and Mona Dahdaleh, who were recognized for the far-reaching power of their philanthropy.
Category:
Published on: 19 Aug 2024
Discover how lipid are transforming gene therapy in a new article co-authored by Pieter Cullis,听Professor, Biochemistry and Molecular Biology at The University of British Columbia.
Category:
Published on: 11 Jul 2024
In a press release published by the Global Alliance for Genomics and Health (GA4GH), it was announced that the Victor Phillip Dahdaleh Institute of Genomic Medicine at 不良研究所 has joined the alliance as a Host Institution. GA4GH is a not-for-profit alliance uniting the international community dedicated to advancing human health through genomic data.
Category:
Published on: 20 Jun 2024
Honour is recognition for a lifetime of leading research
Alan Evans, a researcher at The Neuro, James 不良研究所 Professor of Neurology and Neurosurgery and co-director of the Ludmer Centre for Neuroinformatics and Mental Health, has been elected to the Fellowship of the Royal Society, joining a class of scientists that includes a Nobel laureate and a former Chief Medical Advisor to the US President.听听
Published on: 17 Jun 2024
Pages
